C Lamberti1, T Sauerbruch, A Glasmacher. Show Affiliations » 1. Department of Internal Medicine I, University of Bonn, Germany.
Abstract
Entities: Chemical Disease Species
Mesh： See more » Administration, OralAdolescentAdultAgedAntimetabolites, Antineoplastic/adverse effectsAntimetabolites, Antineoplastic/therapeutic useAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useCapecitabineChemotherapy, AdjuvantColonic Neoplasms/drug therapyColonic Neoplasms/surgeryDeoxycytidine/adverse effectsDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useFemaleFluorouracilHumansInfusions, IntravenousInjections, IntravenousLeucovorin/administration & dosageMaleMiddle AgedSurvival AnalysisTreatment Outcome
Substances： See more » Antimetabolites, AntineoplasticDeoxycytidineCapecitabineLeucovorinFluorouracil
Year: 2005 PMID： 16289340 DOI： 10.1016/j.ctrv.2005.09.009
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111